How has been the historical performance of Saakshi Medtech?
2025-11-15 00:30:47Answer: The historical performance of Saakshi Medtech shows significant fluctuations in key financial metrics over the years. Breakdown: Saakshi Medtech's net sales have decreased from 122.06 Cr in Mar'23 to 92.43 Cr in Mar'25, reflecting a downward trend. The total operating income followed a similar pattern, dropping from 122.06 Cr in Mar'23 to 92.43 Cr in Mar'25. The raw material costs also decreased from 73.93 Cr in Mar'23 to 58.81 Cr in Mar'25, indicating a reduction in production costs. Operating profit (PBDIT) saw a decline from 20.70 Cr in Mar'23 to 10.88 Cr in Mar'25, with the operating profit margin decreasing from 16.84% to 11.15%. Profit before tax fell from 16.59 Cr in Mar'23 to 6.59 Cr in Mar'25, leading to a profit after tax of 4.71 Cr in Mar'25, down from 12.38 Cr in Mar'23. The company's total assets increased from 93.24 Cr in Mar'23 to 131.10 Cr in Mar'25, while total liabilities also ros...
Read MoreIs Saakshi Medtech overvalued or undervalued?
2025-11-07 08:14:36As of 6 November 2025, the valuation grade for Saakshi Medtech has moved from expensive to very expensive. The company is currently overvalued, indicated by a PE ratio of 65.09, an EV to EBITDA ratio of 31.15, and a Price to Book Value of 3.13. In comparison to its peers, Adani Enterprises has a PE ratio of 127.79 and an EV to EBITDA of 29.94, while Tata Chemicals shows a PE of 60.22 and an EV to EBITDA of 16.15, suggesting that Saakshi Medtech's valuation is significantly higher than many of its competitors. The company's recent performance has also been underwhelming, with a year-to-date return of -22.64%, contrasting sharply with the Sensex's gain of 7.89% over the same period. This further reinforces the notion that Saakshi Medtech is not only overvalued but also struggling to deliver returns in the current market environment....
Read MoreWhy is Saakshi Medtech falling/rising?
2025-10-25 00:11:59As of 24-Oct, Saakshi Medtech & Panels Ltd is experiencing a decline in its stock price, currently at 153.40, which reflects a decrease of 3.1 or 1.98%. The stock has underperformed its sector by 1.05% today, despite trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Over the past week, the stock has seen a significant drop of 5.86%, and its year-to-date return stands at a negative 30.27%. Although there has been a notable increase in investor participation, with delivery volume rising by 140% against the 5-day average, the overall performance remains weak, and no positive or negative dashboard insights are available to further explain the stock's recent movement. In the broader market context, the Sensex has shown a positive return of 0.33% over the past week, contrasting sharply with Saakshi Medtech's decline. This indicates that while the overall market is experiencing gains,...
Read MoreWhy is Saakshi Medtech falling/rising?
2025-10-17 23:55:22As of 17-Oct, Saakshi Medtech & Panels Ltd is experiencing a decline in its stock price, currently at 162.95, which reflects a decrease of 0.8 or 0.49%. The stock has underperformed its sector by 1.05% today. Despite this, it is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating some positive momentum in the longer term. Additionally, there has been a significant increase in investor participation, with delivery volume rising by 140% against the 5-day average. However, the stock has shown poor performance over various periods, with a 1-week return of -4.01%, a 1-month return of -15.06%, and a year-to-date decline of 25.93%, suggesting ongoing challenges for the company. In the broader market context, the Sensex has performed positively, with a 1-week return of +1.68% and a year-to-date return of +8.73%. This stark contrast highlights that while the overall market is e...
Read MoreWhy is Saakshi Medtech falling/rising?
2025-09-30 23:39:36As of 30-Sep, Saakshi Medtech & Panels Ltd is experiencing a decline in its stock price, currently at 172.00, which reflects a decrease of 3.5 or 1.99%. The stock has underperformed its sector by 1.05% today. Despite trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, the stock has shown negative returns over various periods, including a 1-week decline of 2.85% and a year-to-date drop of 21.82%. Additionally, while there has been a notable increase in investor participation, with delivery volume rising by 140% against the 5-day average, the absence of specific positive or negative factors makes it difficult to ascertain the precise reasons behind the stock's recent movement. In the broader market context, the stock's short-term performance has been less favorable compared to the benchmark Sensex, which has declined by only 2.22% over the past week. The Sensex has also shown a pos...
Read MoreCorporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available






